Cardiovascular MR Perfusion Imaging: Good Initial Alternative in Stable Chronic Angina

Cardiovascular MR Perfusion ImagingIn the initial management of patients with stable chronic angina, a non-invasive strategy with cardiovascular MR perfusion imaging seems to provide similar results to invasive strategies.

 

At one year, MACE rate (combination of all cause death, non-fatal infarction and target vessel revascularization) resulted 3.3% for MRI vs. 3.9% for fractional flow reserve (FFR) informed invasive strategy. This difference was not significant (p=0.62). Outcomes were similar, despite the lower revascularization rate in the MRI arm (36.0% vs. 44.2%; p= 0.0053).

 

Cardiovascular MR perfusion imaging could be considered the best non-invasive alternative available, since it provides information on anatomy, function and myocardial structure in one single study with no use of iodine radiation.

 

The study randomized 918 patients with chronic stable angina (functional class II or III) at intermediate to high risk of coronary artery disease justified by at least two cardiovascular risk factors and one positive exercise treadmill test. All patients received OMT for risk factor control.

 

The invasive group received angiography and FFR in all >2.5 mm arteries with 40% – 95% stenosis.  Revascularization was performed when FFR value was ˂0.8.

 

We could conclude that non-invasive initial management of stable chronic angina with cardiovascular MRI was non-inferior to angiography with FFR at one year follow up.

 

Original Title: MR-INFORM: stress perfusion imaging to guide the management of patients with stable coronary artery disease.

Presenter: Nagel EC.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...